Breaking News

LGM Pharma Boosts Capabilities with Investment in Analytical Testing & Suppository Manufacturing

Aims to provide customers greater flexibility with a streamlined, efficient, and comprehensive solution for their manufacturing needs.

Author Image

By: Charlie Sternberg

Associate Editor

LGM Pharma, a provider of tailored API and CDMO services for the full drug product lifecycle, has enhanced its capabilities with a 50% expansion and an investment exceeding $2 million in its standalone offering for Analytical Testing Services (ATS) alongside the introduction of new suppository manufacturing capabilities to its contract development and manufacturing (CDMO) portfolio.   These strategic enhancements are designed to provide additional internal bandwidth for growth while also provi...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters